Kestra Private Wealth Services LLC Sells 399 Shares of CVS Health Co. (NYSE:CVS)

Kestra Private Wealth Services LLC lessened its position in CVS Health Co. (NYSE:CVS) by 1.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 36,422 shares of the pharmacy operator’s stock after selling 399 shares during the period. Kestra Private Wealth Services LLC’s holdings in CVS Health were worth $1,635,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of CVS. Integrated Advisors Network LLC increased its position in shares of CVS Health by 0.7% during the 3rd quarter. Integrated Advisors Network LLC now owns 27,625 shares of the pharmacy operator’s stock valued at $1,737,000 after purchasing an additional 200 shares during the last quarter. Widmann Financial Services Inc. grew its position in CVS Health by 1.8% during the third quarter. Widmann Financial Services Inc. now owns 11,506 shares of the pharmacy operator’s stock valued at $724,000 after buying an additional 200 shares during the period. DT Investment Partners LLC increased its holdings in CVS Health by 7.8% during the third quarter. DT Investment Partners LLC now owns 2,777 shares of the pharmacy operator’s stock worth $175,000 after buying an additional 202 shares during the last quarter. United Asset Strategies Inc. raised its position in CVS Health by 2.4% in the third quarter. United Asset Strategies Inc. now owns 9,217 shares of the pharmacy operator’s stock worth $580,000 after acquiring an additional 212 shares during the period. Finally, Albert D Mason Inc. boosted its stake in CVS Health by 1.5% in the third quarter. Albert D Mason Inc. now owns 15,425 shares of the pharmacy operator’s stock valued at $970,000 after acquiring an additional 224 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

NYSE CVS opened at $63.23 on Thursday. The company has a fifty day moving average of $50.61 and a 200-day moving average of $55.92. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The company has a market capitalization of $79.57 billion, a P/E ratio of 16.05, a P/E/G ratio of 0.60 and a beta of 0.61.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. As a group, equities research analysts predict that CVS Health Co. will post 5.14 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.21%. CVS Health’s dividend payout ratio (DPR) is currently 67.51%.

Wall Street Analyst Weigh In

CVS has been the topic of a number of research reports. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Royal Bank of Canada lowered their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. Piper Sandler cut their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research note on Monday, November 25th. Leerink Partners boosted their price objective on CVS Health from $51.00 to $55.00 and gave the company a “market perform” rating in a research note on Tuesday. Finally, TD Cowen increased their target price on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $67.78.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.